Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Knowing when to prioritize financial planning over investment planning can significantly impact your financial success. Find the right balance for your goals.
25,635 articlesWall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Citi upgrades Intuitive Surgical to Buy as market volatility eases, with Stryker placed on a 90-day catalyst watch an...
Honda is recalibrating its EV plan amid slower demand, while REV Group seals a Terex acquisition, creating a pivotal ...
Mercer International posts a brutal Q4 hit from impairment, eroding equity, while International Paper pivots to highe...
Block, Palantir, Atlassian, and Salesforce are in the spotlight as layoffs and hiring pauses test how cost cuts affec...
Solana sits at a pivotal juncture in 2026, with traders weighing a rising wedge against thinning volume and a stubbor...
Nasdaq 100 enters correction territory as the S&P 500 fades in a five-week losing streak, with oil surging and politi...
Deere set to pay a $1.62 quarterly dividend on May 8, 2026, keeping the payout flat for several quarters as investors...
A famed market forecaster is signaling a bold by-year-end target for the S&P 500, driven by resilient earnings and a ...
Atlassian’s AI rollout hit a major roadblock from security rules, limiting early access to 4 of 13,000 employees. Mon...
Dogecoin has risen 25% in the past month, yet a TD Sequential sell signal and a high RSI warn of a potential reversal...
May can bring opportunity for defense stocks as budgets rise and technology drives new capabilities. Here are 3 well-...